- Home
- Publications
- Publication Search
- Publication Details
Title
Antidrug antibodies in psoriasis: a systematic review
Authors
Keywords
-
Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume 170, Issue 2, Pages 261-273
Publisher
Wiley
Online
2013-10-12
DOI
10.1111/bjd.12654
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study
- (2013) S.K. Mahil et al. BRITISH JOURNAL OF DERMATOLOGY
- Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions
- (2013) Jose Ramon Maneiro et al. JAMA Internal Medicine
- Coronary Artery Disease in Patients With Psoriasis Referred for Coronary Angiography
- (2012) April W. Armstrong et al. AMERICAN JOURNAL OF CARDIOLOGY
- Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation
- (2012) Pauline A van Schouwenburg et al. ANNALS OF THE RHEUMATIC DISEASES
- The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis
- (2012) Sandra Garcês et al. ANNALS OF THE RHEUMATIC DISEASES
- Biologic Therapies in the Treatment of Psoriasis: A Comprehensive Evidence-Based Basic Science and Clinical Review and a Practical Guide to Tuberculosis Monitoring
- (2012) Raja K. Sivamani et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Plasma trough levels of adalimumab and infliximab in terms of clinical efficacy during the treatment of psoriasis
- (2012) Hidetoshi Takahashi et al. JOURNAL OF DERMATOLOGY
- Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
- (2012) A.B. Kimball et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Off-Label Biologic Regimens in Psoriasis: A Systematic Review of Efficacy and Safety of Dose Escalation, Reduction, and Interrupted Biologic Therapy
- (2012) Elizabeth A. Brezinski et al. PLoS One
- Psoriasis and the Risk of Diabetes Mellitus
- (2012) April W. Armstrong et al. JAMA Dermatology
- Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction
- (2011) J.H.O. Hoffmann et al. BRITISH JOURNAL OF DERMATOLOGY
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)
- (2011) Tsen-Fang Tsai et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Differential effect of drug interference in immunogenicity assays
- (2011) Margreet H. Hart et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study
- (2011) Alice B. Gottlieb et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis
- (2010) Lidian L. A. Lecluse et al. ARCHIVES OF DERMATOLOGY
- Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
- (2010) P. ETTEHADI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Dealing with immunogenicity of biologicals: assessment and clinical relevance
- (2010) Gerrit J Wolbink et al. CURRENT OPINION IN RHEUMATOLOGY
- Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial
- (2010) Hideshi Torii et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Anti-infliximab antibody status and its relation to clinical response in psoriatic patients: A pilot study
- (2010) Esra ADIŞEN et al. JOURNAL OF DERMATOLOGY
- Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma
- (2010) Hideshi TORII et al. JOURNAL OF DERMATOLOGY
- Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
- (2010) Akihiko ASAHINA et al. JOURNAL OF DERMATOLOGY
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review
- (2010) Charlotte Krieckaert et al. ARTHRITIS RESEARCH & THERAPY
- Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases
- (2009) Nádia Emi Aikawa et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
- (2009) Alice Gottlieb et al. LANCET
- The Combination of Etanercept and Methotrexate Increases the Effectiveness of Treatment in Active Psoriasis Despite Inadequate Effect of Methotrexate Therapy
- (2008) C Zachariae et al. ACTA DERMATO-VENEREOLOGICA
- Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
- (2008) M K de Vries et al. ANNALS OF THE RHEUMATIC DISEASES
- Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
- (2008) Hiroki Mitoma et al. ARTHRITIS AND RHEUMATISM
- The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004
- (2008) Shanu Kohli Kurd et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started